J&J bulks up

In contrast to the Kraft item below, Johnson & Johnson is planning to buy Pfizer's consumer health division for $16.6b.

Pfizer has had the division on the block for the past couple months. We reported about three weeks ago that J&J was among the leading bidders, along with Glaxo and Reckitt Benckiser.